{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T23:19:56Z","timestamp":1778282396912,"version":"3.51.4"},"reference-count":110,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxicon"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1016\/j.toxicon.2008.11.013","type":"journal-article","created":{"date-parts":[[2008,12,7]],"date-time":"2008-12-07T05:20:53Z","timestamp":1228627253000},"page":"614-623","source":"Crossref","is-referenced-by-count":74,"title":["Disease-oriented approach to botulinum toxin use"],"prefix":"10.1016","volume":"54","author":[{"given":"Joseph","family":"Jankovic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxicon.2008.11.013_bib109","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1111\/j.1572-0241.2003.07514.x","article-title":"Treatment of outlet obstruction constipation in Parkinson's disease with botulinum neurotoxin A","volume":"98","author":"Albanese","year":"2003","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.toxicon.2008.11.013_bib102","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00702-007-0862-x","article-title":"The use of botulinum neurotoxin type A (BoNTA) in urology","volume":"115","author":"Apostolidis","year":"2008","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.toxicon.2008.11.013_bib103","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1136\/jnnp.68.4.429","article-title":"Assessment of voiding dysfunction in Parkinson's disease by the international prostate symptom score","volume":"68","author":"Araki","year":"2000","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.toxicon.2008.11.013_bib25","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1136\/jnnp.59.3.309","article-title":"Pretarsal application of botulinum toxin for treatment of blepharospasm","volume":"59","author":"Aramideh","year":"1995","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.toxicon.2008.11.013_bib37","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1002\/mds.21058","article-title":"Joint and skeletal deformities in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy","volume":"21","author":"Ashour","year":"2006","journal-title":"Mov. Disord."},{"key":"10.1016\/j.toxicon.2008.11.013_bib36","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S1474-4422(05)70119-8","article-title":"Striatal deformities of the hand and foot in Parkinson's disease","volume":"4","author":"Ashour","year":"2005","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.toxicon.2008.11.013_bib47","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1212\/01.wnl.0000171857.09079.9f","article-title":"Camptocormia: pathogenesis, classification, and response to therapy","volume":"65","author":"Azher","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.toxicon.2008.11.013_bib13","series-title":"3rd Series","first-page":"461","article-title":"Clinical aspects of progressive supranuclear palsy","volume":"89","author":"Azher","year":"2008"},{"key":"10.1016\/j.toxicon.2008.11.013_bib33","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1053\/smrv.1999.0070","article-title":"Sleep bruxism: overview of an oromandibular sleep movement disorders","volume":"4","author":"Bader","year":"2000","journal-title":"Sleep Med. Rev."},{"key":"10.1016\/j.toxicon.2008.11.013_bib90","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0194-5998(97)70267-5","article-title":"Use of botulinum toxin for diagnosis and management of cricopharyngeal achalasia","volume":"116","author":"Blitzer","year":"1997","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.toxicon.2008.11.013_bib49","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1136\/jnnp.2006.087908","article-title":"Parkinson's disease with camptocormia","volume":"77","author":"Bloch","year":"2006","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.toxicon.2008.11.013_bib46","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1002\/mds.21694","article-title":"Botulinum toxin treatment of lateral axial dystonia in parkinsonism","volume":"22","author":"Bonanni","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.toxicon.2008.11.013_bib56","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1212\/WNL.56.11.1523","article-title":"A\u00a0randomized, double masked, controlled trial of botulinum toxin type A in essential hand tremor","volume":"56","author":"Brin","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.toxicon.2008.11.013_bib110","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1111\/j.1365-2036.2005.02669.x","article-title":"Outlet type constipation in Parkinson's disease: results of botulinum toxin treatment","volume":"22","author":"Cadeddu","year":"2005","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.toxicon.2008.11.013_bib29","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/PL00007849","article-title":"Comparison of preseptal and pretarsal injections of botulinum toxin in the treatment of blepharospasm and hemifacial spasm","volume":"249","author":"Cakmur","year":"2002","journal-title":"J. Neurol."},{"key":"10.1016\/j.toxicon.2008.11.013_bib105","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1016\/j.juro.2006.07.127","article-title":"The application of botulinum toxin in the prostate","volume":"176","author":"Chuang","year":"2006","journal-title":"J. Urol."},{"key":"10.1016\/j.toxicon.2008.11.013_bib24","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1136\/jnnp.74.5.687","article-title":"Botulinum toxin type B in blepharospasm and hemifacial spasm","volume":"74","author":"Colosimo","year":"2003","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.toxicon.2008.11.013_bib40","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/mds.1186","article-title":"Treatment of dystonic clenched fist with botulinum toxin","volume":"16","author":"Cordivari","year":"2001","journal-title":"Mov. Disord."},{"key":"10.1016\/j.toxicon.2008.11.013_bib65","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00005053-195801000-00003","article-title":"The nature of apraxia","volume":"126","author":"Denny Brown","year":"1958","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.toxicon.2008.11.013_bib54","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1473-2165.2006.00250.x","article-title":"Botulinum toxin in dermatology \u2013 beyond wrinkles and sweat","volume":"5","author":"Diamond","year":"2006","journal-title":"J. Cosmet. Dermatol."},{"key":"10.1016\/j.toxicon.2008.11.013_bib4","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1586\/14737175.6.8.1181","article-title":"Treatment of advanced Parkinson's disease","volume":"6","author":"Diamond","year":"2006","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.toxicon.2008.11.013_bib84","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.clineuro.2003.10.012","article-title":"Ultrasound-guided versus \u2018blind\u2019 intraparotid injections of botulinum toxin-A for the treatment of sialorrhoea in patients with Parkinson's disease","volume":"106","author":"Dogu","year":"2004","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.toxicon.2008.11.013_bib30","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.survophthal.2006.10.003","article-title":"Botulinum toxin in ophthalmology","volume":"52","author":"Dutton","year":"2007","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.toxicon.2008.11.013_bib91","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1023\/A:1018843526027","article-title":"Untoward effects of esophageal botulinum toxin injection in the treatment of achalasia","volume":"42","author":"Eaker","year":"1997","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.toxicon.2008.11.013_bib14","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1136\/jnnp.55.5.369","article-title":"A new variant of blepharospasm","volume":"55","author":"Elston","year":"1992","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.toxicon.2008.11.013_bib61","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.clineuro.2007.05.020","article-title":"Hereditary chin tremor in Parkinson's disease","volume":"109","author":"Erer","year":"2007","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.toxicon.2008.11.013_bib68","first-page":"282","article-title":"Botulinum toxin type B for gait freezing in Parkinson's disease","volume":"10","author":"Fernandez","year":"2004","journal-title":"Med. Sci. Monit."},{"issue":"58","key":"10.1016\/j.toxicon.2008.11.013_bib26","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1212\/WNL.58.12.1843","article-title":"Botulinum toxin improves lid opening delays in blepharospasm-associated apraxia of lid opening","volume":"25","author":"Forget","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.toxicon.2008.11.013_bib76","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S1353-8020(00)00073-0","article-title":"Quantitative assessment of parkinsonian sialorrhea and results of treatment with botulinum toxin","volume":"7","author":"Friedman","year":"2001","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.toxicon.2008.11.013_bib66","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/mds.870120641","article-title":"Botulinum toxin injections to one leg alleviate freezing of gait in a patient with Parkinson's disease","volume":"12","author":"Giladi","year":"1997","journal-title":"Mov. Disord."},{"key":"10.1016\/j.toxicon.2008.11.013_bib38","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1136\/jnnp.57.5.659","article-title":"The use of botulinum toxin to treat \u201cstriatal\u201d toes","volume":"57","author":"Giladi","year":"1994","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.toxicon.2008.11.013_bib67","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1007\/s004150170134","article-title":"The effect of botulinum toxin injections to the calf muscles on freezing of gait in parkinsonism: a pilot study","volume":"248","author":"Giladi","year":"2001","journal-title":"J. Neurol."},{"key":"10.1016\/j.toxicon.2008.11.013_bib63","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1212\/WNL.56.12.1712","article-title":"Freezing of gait in PD. Prospective assessment of the DATATOP cohort","volume":"56","author":"Giladi","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.toxicon.2008.11.013_bib20","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/mds.870110107","article-title":"Unilateral injection of botulinum toxin in blepharospasm: single fiber electromyography and blink reflex study","volume":"11","author":"Girlanda","year":"1996","journal-title":"Mov. Disord."},{"key":"10.1016\/j.toxicon.2008.11.013_bib95","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0733-8635(03)00028-7","article-title":"Seborrheic dermatitis","volume":"21","author":"Gupta","year":"2003","journal-title":"Dermatol. Clin."},{"key":"10.1016\/j.toxicon.2008.11.013_bib69","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1002\/mds.21396","article-title":"The effect of injecting botulinum toxin type A into the calf muscles on freezing of gait in Parkinson's disease: a double blind placebo-controlled pilot study","volume":"22","author":"Gurevich","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.toxicon.2008.11.013_bib9","doi-asserted-by":"crossref","unstructured":"Hallett, M., Evinger, C., Jankovic, J., Stacy, M., 2008. Update on blepharospasm. Report from BEBRF International Workshop 2006. Neurology 71, 1275\u201382.","DOI":"10.1212\/01.wnl.0000327601.46315.85"},{"key":"10.1016\/j.toxicon.2008.11.013_bib51","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1002\/mds.21090","article-title":"Effect of deep brain subthalamic stimulation on camptocormia and postural abnormalities in idiopathic Parkinson's disease","volume":"21","author":"Hellmann","year":"2006","journal-title":"Mov. Disord."},{"key":"10.1016\/j.toxicon.2008.11.013_bib59","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000117196","article-title":"Botulinum toxin A in nondystonic tremors","volume":"36","author":"Henderson","year":"1996","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.toxicon.2008.11.013_bib44","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/mds.10704","article-title":"Computed tomographically-controlled injection of botulinum toxin into the longus colli muscle in severe anterocollis","volume":"19","author":"Herting","year":"2004","journal-title":"Mov. Disord."},{"key":"10.1016\/j.toxicon.2008.11.013_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2007.12.001","article-title":"Dystonic frowning without blepharospasm","author":"Hirota","year":"2008","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.toxicon.2008.11.013_bib60","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/mds.870050117","article-title":"Uniform frequency of parkinsonian resting tremor in the lips, jaw, tongue and index finger","volume":"5","author":"Hunker","year":"1990","journal-title":"Mov. Disord."},{"key":"10.1016\/j.toxicon.2008.11.013_bib31","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1159\/000104713","article-title":"Botulinum toxin injection into Riolan's muscle: somatosensory \u2018trick\u2019","volume":"58","author":"Inoue","year":"2007","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.toxicon.2008.11.013_bib8","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1212\/WNL.37.4.616","article-title":"Botulinum A toxin for cranial\u2013cervical dystonia: a double-blind, placebo-controlled study","volume":"37","author":"Jankovic","year":"1987","journal-title":"Neurology"},{"key":"10.1016\/j.toxicon.2008.11.013_bib57","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1212\/WNL.41.8.1185","article-title":"Botulinum toxin treatment of tremors","volume":"41","author":"Jankovic","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.toxicon.2008.11.013_bib11","doi-asserted-by":"crossref","first-page":"677","DOI":"10.2165\/00023210-200721080-00005","article-title":"Medical management of levodopa-associated motor complications in patients with Parkinson's disease","volume":"21","author":"Jankovic","year":"2007","journal-title":"CNS Drugs"},{"key":"10.1016\/j.toxicon.2008.11.013_bib10","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S1353-8020(01)00025-6","article-title":"Dystonia and parkinsonism","volume":"8","author":"Jankovic","year":"2001","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.toxicon.2008.11.013_bib55","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/mds.870110306","article-title":"A\u00a0randomized double-blind, placebo controlled study to evaluate botulinum toxin A in essential hand tremor","volume":"11","author":"Jankovic","year":"1996","journal-title":"Mov. Disord."},{"key":"10.1016\/j.toxicon.2008.11.013_bib53","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1136\/jnnp.67.5.646","article-title":"Re-emergent tremor of Parkinson's disease","volume":"67","author":"Jankovic","year":"1999","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.toxicon.2008.11.013_bib88","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1212\/01.wnl.0000249308.66959.43","article-title":"Clinico-immunologic aspects of botulinum toxin type B treatment of cervical dystonia","volume":"67","author":"Jankovic","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.toxicon.2008.11.013_bib2","series-title":"Botulinum and Other Neurotoxins: Translating Science into Therapeutic Applications","author":"Jankovic","year":"2008"},{"key":"10.1016\/j.toxicon.2008.11.013_bib27","first-page":"686","article-title":"Apraxia of lid opening","volume":"10","author":"Jankovic","year":"1995","journal-title":"Mov. Disord."},{"key":"10.1016\/j.toxicon.2008.11.013_bib16","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1136\/jnnp.2003.034702","article-title":"Botulinum toxin in clinical practice","volume":"75","author":"Jankovic","year":"2004","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"Suppl. 11","key":"10.1016\/j.toxicon.2008.11.013_bib35","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1002\/mds.20458","article-title":"Motor fluctuations and dyskinesias in Parkinson's disease: clinical manifestations","volume":"20","author":"Jankovic","year":"2005","journal-title":"Mov. Disord."},{"key":"10.1016\/j.toxicon.2008.11.013_bib41","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF03033933","article-title":"Botulinum toxin therapy for cervical dystonia","volume":"9","author":"Jankovic","year":"2006","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.toxicon.2008.11.013_bib7","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/S1474-4422(06)70574-9","article-title":"Treatment of dystonia","volume":"5","author":"Jankovic","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.toxicon.2008.11.013_bib3","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","article-title":"Parkinson's disease: clinical features and diagnosis","volume":"79","author":"Jankovic","year":"2008","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.toxicon.2008.11.013_bib89","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s00455-001-0063-y","article-title":"Repetitive proximal esophageal contractions: a new manometric finding and a possible further link between Parkinson's disease and achalasia","volume":"16","author":"Johnston","year":"2001","journal-title":"Dysphagia"},{"key":"10.1016\/j.toxicon.2008.11.013_bib75","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1002\/1531-8257(199911)14:6<1057::AID-MDS1033>3.0.CO;2-4","article-title":"Treatment of drooling in Parkinson's disease with botulinum toxin","volume":"14","author":"Jost","year":"1999","journal-title":"Mov. Disord."},{"key":"10.1016\/j.toxicon.2008.11.013_bib18","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s00702-007-0768-7","article-title":"Botulinum toxin in the treatment of blepharospasm and hemifacial spasm","volume":"115","author":"Kenney","year":"2008","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.toxicon.2008.11.013_bib15","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/mds.870090605","article-title":"\u2018Apraxia of lid opening.\u2019 A focal eyelid dystonia: clinical study of 32 patients","volume":"9","author":"Krack","year":"1994","journal-title":"Mov. Disord."},{"key":"10.1016\/j.toxicon.2008.11.013_bib64","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/mds.21917","article-title":"Bilateral pedunculopontine nuclei stroke presenting as freezing of gait","volume":"23","author":"Kuo","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.toxicon.2008.11.013_bib81","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/mds.20793","article-title":"Botulinum toxin type A for drooling in Parkinson's disease: a double-blind, randomized, placebo-controlled study","volume":"21","author":"Lagalla","year":"2006","journal-title":"Mov. Disord."},{"key":"10.1016\/j.toxicon.2008.11.013_bib28","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/mds.870100425","article-title":"Botulinum A toxin for the so-called apraxia of lid opening","volume":"10","author":"Lepore","year":"1995","journal-title":"Mov. Disord."},{"key":"10.1016\/j.toxicon.2008.11.013_bib48","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1136\/jnnp.2005.083998","article-title":"A specific clinical pattern of camptocormia in Parkinson's disease","volume":"77","author":"Lepoutre","year":"2006","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.toxicon.2008.11.013_bib6","first-page":"73","article-title":"Botulinum toxin: description of injection techniques and examination of controversies surrounding toxin diffusion","volume":"117","author":"Lim","year":"2008","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.toxicon.2008.11.013_bib86","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1212\/WNL.61.9.1279","article-title":"A\u00a0randomized trial of botulinum toxin A for treatment of drooling","volume":"61","author":"Lipp","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.toxicon.2008.11.013_bib77","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/mds.10420","article-title":"Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism","volume":"18","author":"Mancini","year":"2003","journal-title":"Mov. Disord."},{"key":"10.1016\/j.toxicon.2008.11.013_bib108","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1136\/jnnp.51.12.1503","article-title":"Constipation and paradoxical puborectalis contraction in anismus and Parkinson's disease: a dystonic phenomenon?","volume":"51","author":"Mathers","year":"1988","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.toxicon.2008.11.013_bib17","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/mds.20376","article-title":"Long-term botulinum toxin efficacy, safety and immunogenicity","volume":"20","author":"Mejia","year":"2005","journal-title":"Mov. Disord."},{"key":"10.1016\/j.toxicon.2008.11.013_bib50","first-page":"1005","article-title":"Camptocormia in Parkinson's disease","volume":"78","author":"Melamed","year":"2007","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"Suppl. 1","key":"10.1016\/j.toxicon.2008.11.013_bib42","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0733-8619(08)80004-7","article-title":"Role of botulinum toxin in the treatment of cervical dystonia","volume":"26","author":"Molho","year":"2008","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.toxicon.2008.11.013_bib83","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/01.wco.0000280411.57836.aa","article-title":"Treatment of sialorrhoea in patients with Parkinson's disease: best current evidence","volume":"20","author":"Molloy","year":"2007","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.toxicon.2008.11.013_bib99","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2310\/7750.2007.00012","article-title":"Treatment of focal hyperhidrosis","volume":"11","author":"Murray","year":"2007","journal-title":"J. Cutan. Med. Surg."},{"key":"10.1016\/j.toxicon.2008.11.013_bib101","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1212\/01.wnl.0000311390.87642.d8","volume":"70","author":"Naumann","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.toxicon.2008.11.013_bib79","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jns.2006.11.015","article-title":"Does botulinum toxin decrease frequency and severity of sialorrhea in Parkinson's disease?","volume":"253","author":"N\u00f3brega","year":"2007","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.toxicon.2008.11.013_bib80","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1212\/01.WNL.0000101713.81253.4C","article-title":"A double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson's disease","volume":"62","author":"Ondo","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.toxicon.2008.11.013_bib39","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/mds.870100317","article-title":"\u201cOff\u201d painful dystonia in Parkinson's disease treated with botulinum toxin","volume":"10","author":"Pacchetti","year":"1995","journal-title":"Mov. Disord."},{"key":"10.1016\/j.toxicon.2008.11.013_bib85","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1212\/WNL.54.1.244","article-title":"Botulinum toxin A as treatment for drooling saliva in PD","volume":"54","author":"Pal","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.toxicon.2008.11.013_bib45","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000109265","article-title":"Retrocollis: classification, clinical phenotype, treatment outcomes and risk factors","volume":"59","author":"Papapetropoulos","year":"2007","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.toxicon.2008.11.013_bib92","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1056\/NEJM199503233321203","article-title":"Intrasphincteric botulinum toxin for the treatment of achalasia","volume":"322","author":"Pasricha","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.toxicon.2008.11.013_bib104","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.eururo.2006.07.022","article-title":"Botulinum toxin injections for neurogenic and idiopathic detrusor overactivity: a critical analysis of results","volume":"50","author":"Patel","year":"2006","journal-title":"Eur. Urol."},{"key":"10.1016\/j.toxicon.2008.11.013_bib106","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1474-4422(03)00307-7","article-title":"Gastrointestinal dysfunction in Parkinson's disease","volume":"2","author":"Pfeiffer","year":"2003","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.toxicon.2008.11.013_bib73","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s004150070091","article-title":"Non-invasive assessment of swallowing and respiration in Parkinson's disease","volume":"247","author":"Pinnington","year":"2000","journal-title":"J. Neurol."},{"key":"10.1016\/j.toxicon.2008.11.013_bib93","first-page":"297","article-title":"Achalasia: an overview of diagnosis and treatment","volume":"16","author":"Pohl","year":"2007","journal-title":"J. Gastrointestin. Liver Dis."},{"key":"10.1016\/j.toxicon.2008.11.013_bib71","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/mds.20189","article-title":"Salivary production in Parkinson's disease","volume":"20","author":"Proulx de Courval","year":"2005","journal-title":"Mov. Disord."},{"key":"10.1016\/j.toxicon.2008.11.013_bib98","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1002\/mds.21422","article-title":"Sweating in parkinsonian patients with wearing-off","volume":"22","author":"Pursiainen","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.toxicon.2008.11.013_bib78","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1002\/mds.10484","article-title":"Botulinum toxin B reduces sialorrhea in parkinsonism","volume":"18","author":"Racette","year":"2003","journal-title":"Mov. Disord."},{"key":"10.1016\/j.toxicon.2008.11.013_bib23","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/01.WNF.0000236771.77021.3C","article-title":"A double-blind, randomized, crossover study of prosigne versus botox in patients with blepharospasm and hemifacial spasm","volume":"30","author":"Rieder","year":"2007","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.toxicon.2008.11.013_bib21","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00702-005-0323-3","article-title":"Efficacy and safety of a new botulinum toxin type A free of complexing proteins in the treatment of blepharospasm","volume":"113","author":"Roggenkamper","year":"2006","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.toxicon.2008.11.013_bib107","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1136\/jnnp.74.2.268","article-title":"Colonic transit time and rectoanal videomanometry in Parkinson's disease","volume":"74","author":"Sakakibara","year":"2003","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.toxicon.2008.11.013_bib82","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/j.1532-5415.2008.01612.x","article-title":"Botulinum toxin type A in the treatment of sialorrhea in Parkinson's disease","volume":"56","author":"Santamato","year":"2008","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.toxicon.2008.11.013_bib97","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1002\/mds.21006","article-title":"Hyperhidrosis in Parkinson's disease","volume":"21","author":"Schestatsky","year":"2006","journal-title":"Mov. Disord."},{"key":"10.1016\/j.toxicon.2008.11.013_bib94","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000016845","article-title":"Use of botulinum toxin in the treatment of achalasia","volume":"16","author":"Schiano","year":"1998","journal-title":"Dig. Dis."},{"key":"10.1016\/j.toxicon.2008.11.013_bib62","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1002\/mds.21019","article-title":"Botulinum toxin A may be efficacious as treatment for jaw tremor in Parkinson's disease","volume":"21","author":"Schneider","year":"2006","journal-title":"Mov. Disord."},{"key":"10.1016\/j.toxicon.2008.11.013_bib5","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1586\/14737175.7.6.637","article-title":"Botulinum toxin in the treatment of tremors, dystonias, sialorrhea and other symptoms associated with Parkinson's disease","volume":"7","author":"Sheffield","year":"2007","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.toxicon.2008.11.013_bib19","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1212\/01.wnl.0000311389.26145.95","volume":"70","author":"Simpson","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.toxicon.2008.11.013_bib100","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1111\/j.1524-4725.2007.33192.x","article-title":"A comprehensive approach to the recognition, diagnosis, and severity-based treatment of focal hyperhidrosis: recommendations of the Canadian hyperhidrosis advisory committee","volume":"33","author":"Solish","year":"2007","journal-title":"Dermatol. Surg."},{"key":"10.1016\/j.toxicon.2008.11.013_bib12","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s004150050347","article-title":"Idiopathic blepharospasm does not lead to a parkinsonian syndrome: results of a questionnaire-based follow-up study","volume":"246","author":"Soonawala","year":"1999","journal-title":"J. Neurol."},{"key":"10.1016\/j.toxicon.2008.11.013_bib96","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1002\/mds.10586","article-title":"Sweating dysfunction in Parkinson's disease","volume":"18","author":"Swinn","year":"2003","journal-title":"Mov. Disord."},{"key":"10.1016\/j.toxicon.2008.11.013_bib34","doi-asserted-by":"crossref","first-page":"211","DOI":"10.14219\/jada.archive.2000.0149","article-title":"Treating severe bruxism with botulinum toxin","volume":"131","author":"Tan","year":"2000","journal-title":"J. Am. Dent. Assoc."},{"key":"10.1016\/j.toxicon.2008.11.013_bib87","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1212\/01.wnl.0000174433.76707.8c","article-title":"Autonomic function after botulinum toxin type A or B: a double-blind, randomized trial","volume":"65","author":"Tintner","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.toxicon.2008.11.013_bib58","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/mds.870090604","article-title":"Botulinum toxin A injections for the treatment of hand tremor","volume":"9","author":"Trosch","year":"1994","journal-title":"Mov. Disord."},{"key":"10.1016\/j.toxicon.2008.11.013_bib1","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.parkreldis.2006.06.002","article-title":"Botulinum toxin: clinical use","volume":"12","author":"Truong","year":"2006","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.toxicon.2008.11.013_bib22","doi-asserted-by":"crossref","unstructured":"Truong, D., Comella, C., Fernandez, H.H., Ondo, W.G., 2008. Dysport Benign Essential Blepharospasm Study Group. Efficacy and safety of purified botulinum toxin type A (Dysport\u00ae) for the treatment of benign essential blepharospasm: a randomized, placebo-controlled, phase II trial. Parkinsonism Relat. Disord. 4, 407\u201314.","DOI":"10.1016\/j.parkreldis.2007.11.003"},{"key":"10.1016\/j.toxicon.2008.11.013_bib74","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1345\/aph.1C019","article-title":"Sialorrhea \u2013 therapeutic drug options","volume":"36","author":"Tscheng","year":"2002","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.toxicon.2008.11.013_bib72","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/mds.20784","article-title":"Quantitative study of salivary secretion in Parkinson's disease","volume":"21","author":"Tumilasci","year":"2006","journal-title":"Mov. Disord."},{"key":"10.1016\/j.toxicon.2008.11.013_bib43","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1002\/mds.21634","article-title":"The phenomenon of disproportionate antecollis in Parkinson's disease and multiple system atrophy","volume":"22","author":"van de Warrenburg","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.toxicon.2008.11.013_bib52","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/mds.21967","article-title":"Ultrasound-guided injection of the iliopsoas muscle with botulinum toxin in camptocormia","volume":"23","author":"von Coelln","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.toxicon.2008.11.013_bib70","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1212\/01.wnl.0000172930.63669.c8","article-title":"Botulinum toxin injections do not improve freezing of gait in Parkinson disease","volume":"65","author":"Wieler","year":"2005","journal-title":"Neurology"}],"container-title":["Toxicon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010108006053?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010108006053?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T21:44:44Z","timestamp":1557956684000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041010108006053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":110,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S0041010108006053"],"URL":"https:\/\/doi.org\/10.1016\/j.toxicon.2008.11.013","relation":{},"ISSN":["0041-0101"],"issn-type":[{"value":"0041-0101","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}